retatrutide clinical trial results weight loss 2024 2025 press release Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. Adam Retatrutide: Phase 3 Results (Up
Pay in 4 interest-free payments of $6.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28


















.webp?width=900&height=1201&name=Semaglutide%20Image%202_900x1200%20(without%20phone).webp)






